Work

Echocardiography-Guided Anticoagulation for Atrial Fibrillation in a Patient With Malignancy

Year: 2024

Type: article

Abstract: Per current guidelines, anticoagulation strategy for atrial fibrillation (AF) is determined by the patient's CHA2DS2-VASc score, the benefits and risks of which have been well demonstrated by large-scale clinical trials and registries. In the last decade, non–vitamin K antagonist oral anticoagulants (NOACs) have become the anticoagulants of choice and are prescribed as the default in most patients with AF in place of warfarin. However, the role of NOACs in the presence of malignancy is not well established.

Source: CASE

DOI: 10.1016/j.case.2024.07.002

Authors: Songnan Wen, Tasneem Z. Naqvi

Institutions: Mayo Clinic, Mayo Clinic Hospital

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $950